Table 2.
Phase I sample* | Phase II sample** | |||
---|---|---|---|---|
|
|
|||
Controls (n = 9) | TBI (n = 10) | Controls (n = 39) | TBI (n = 41) | |
Age | 74.1 (71–90) | 77.0 (65–87) | 42.8 (22–76) | 42.7 (21–81) |
% Male | 33% | 40% | 69% | 68% |
Mechanism of injury (%) | n/a | MVC 30 | n/a | MVC 41.5 |
Fall 70 | Pedestrian 9.8 | |||
Fall 21.9 | ||||
Assault 12.2 | ||||
Other 14.6 | ||||
Initial ED GCS | n/a | 14.1 (10–15) | n/a | 14.9 (14–15) |
Confirmed loss of consciousness (%) | n/a | Data not available | n/a | 54% |
Possible loss/altered consciousness (%) | n/a | n/a | 19.5% | |
Post-traumatic amnesia (%) | n/a | n/a | 48.8% | |
% having head CT performed | n/a | 100% | n/a | 75.6% |
% CTs positive for intracranial pathology | 90% | 29% | ||
Injury severity score (ISS)** | n/a | 17.1 (95% CI 11.3; 25.3)) | n/a | 5.6 (95% CI 4.2; 7.0)) |
GOS-E | n/a | n/a | ||
3 months | 6.1 (4–8) | 7.6 (5–8) | ||
6 months | 6.2 (4–8) | 7.7 (5–8) |
Phase I sample only enrolled older subjects.
Phase II sample restricted enrollment to AIS < 3 in systems other than head. n/a = not available